指南与共识呼吸衰竭与机械通气

重症哮喘支气管热成形术:专家组的best practice推荐

Bronchial Thermoplasty in Severe Asthma: Best Practice Recommendations from an Expert Panel.
指南 / 共识 · Respiration · 2018-04-17
一句话结论专家组推荐:重症哮喘患者在第5级治疗仍症状控制不佳时,可考虑支气管热成形术,需分3次支气管镜 sessions 完成。

本文是介入肺脏病学与重症哮喘专家组的best practice推荐,聚焦支气管热成形术(BT)的背景与实操。随机对照临床试验显示BT安全有效,可减少重症哮喘患者的严重急性发作、改善生活质量并减少急诊就诊;5年随访显示临床获益持续且功能稳定。GINA指南指出BT可作为成人第5级哮喘的治疗选择。患者选择需介入肺脏病学家与重症哮喘专家密切协作,治疗分3次支气管镜 sessions、间隔至少3周,围术期口服泼尼松龙50 mg/天共5天(术前3天开始)。

要点

  • GINA指南指出,BT可作为成人第5级哮喘患者的治疗选择。
  • BT适用于尽管接受最佳药物治疗仍症状持续的重症哮喘患者。
  • BT分3次支气管镜 sessions 进行,每次间隔至少3周,分别覆盖不同肺区域。
  • 围术期予泼尼松龙50 mg/天或等效剂量共5天,从操作前3天开始。
  • 主要围术期不良事件为哮喘症状加重、咳嗽和痰量增加,偶见肺不张。

适用人群与场景

  • 尽管接受最佳药物治疗仍症状持续的重症哮喘患者。
  • GINA指南将BT列为成人哮喘第5级治疗的可考虑选项。
  • 患者选择需介入肺脏病学家与重症哮喘专家密切协作。

诊断标准与关键阈值

  • GINA指南:BT可作为成人哮喘第5级患者的治疗选择。
  • 患者选择需介入肺脏病学家与重症哮喘专家密切协作,具体选择标准见原文所述。

处置流程与药物剂量

  • BT分3次独立的支气管镜 sessions 进行,每次间隔至少3周,分别覆盖不同肺区域。
  • 围术期予泼尼松龙50 mg/天或等效剂量共5天,从操作前3天开始。
  • 操作在中度至深度镇静或全身麻醉下进行。
  • 经支气管镜工作通道置入一次性篮状设计导管,由射频发生器(AlairTM Bronchial Thermoplasty System)释放能量。
  • 采用温度控制射频能量,作用于气道重塑,包括减少气道壁内过度增生的气道平滑肌。
  • 治疗应系统进行,从(亚)段气道最远端开始,向近端移动至主支气管,确保大部分气道得到治疗。
  • 一般下叶给予40–70次射频激活,上叶合计给予50–100次激活。

红旗征与不能漏的情况

  • 主要围术期不良事件为哮喘症状加重、咳嗽和痰量增加。
  • 术后偶见肺不张。

研究设计与关键结果

  • 随机对照临床试验显示BT安全有效,可减少严重急性发作、改善生活质量并减少急诊就诊。
  • 5年随访研究显示接受BT治疗的患者功能稳定,临床获益持续。
  • BT长期安全性极好。

证据类型、等级与局限

  • 证据类型:专家组best practice推荐。
  • 随机对照临床试验显示BT安全有效。
  • 5年随访研究提供功能稳定和临床获益持续的证据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对第5级重症哮喘仍症状持续者,可考虑转诊评估BT。
  • 实施BT需介入肺脏病学家与重症哮喘专家协作选择患者。
  • 围术期按方案予泼尼松龙50 mg/天或等效剂量共5天,从操作前3天开始。
  • 操作在中等至深度镇静或全身麻醉下进行,分3次 sessions、间隔至少3周。
  • 作者指出,最佳BT应答者特征(即哪种哮喘表型获益最大)是当前研究热点。

指南或共识出处

  • 全球哮喘防治创议(GINA)指南

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Bronchial thermoplasty (BT) is a bronchoscopic treatment for patients with severe asthma who remain symptomatic despite optimal medical therapy. In this "expert best practice" paper, the background and practical aspects of BT are highlighted. Randomized, controlled clinical trials have shown BT to be safe and effective in reducing severe exacerbations, improving quality of life, and decreasing emergency department visits. Five-year follow-up studies have provided evidence of the functional stability of BT-treated patients with persistence of a clinical benefit. The Global Initiative for Asthma (GINA) guidelines state that BT can be considered as a treatment option for adult asthma patients at step 5. Patient selection for BT requires close collaboration between interventional pulmonologists and severe asthma specialists. Key patient selection criteria for BT will be reviewed. BT therapy is delivered in 3 separate bronchoscopy sessions at least 3 weeks apart, covering different regions of the lung separately. Patients are treated with 50 mg/day of prednisolone or equivalent for 5 days, starting treatment 3 days prior to the procedure. The procedure is performed under moderate-to-deep sedation or general anesthesia. At bronchos-copy a single-use catheter with a basket design is inserted through the instrument channel and the energy is delivered by a radiofrequency (RF) generator (AlairTM Bronchial Thermoplasty System). BT uses temperature-controlled RF energy to impact airway remodeling, including a reduction of excessive airway smooth muscle within the airway wall, which has been recognized as a predominant feature of asthma. The treatment should be performed in a systemic manner, starting at the most distal part of the (sub)segmental airway, then moving proximally to the main bronchi, ensuring that the majority of the airways are treated. In general, 40-70 RF activations are provided in the lower lobes, and between 50 and 100 activations in the upper lobes combined. The main periprocedural adverse events are exacerbation of asthma symptoms and increased cough and sputum production. Occasionally, atelectasis has been observed following the procedure. The long-term safety of BT is excellent. An optimized BT responder profile - i.e., which specific asthma phenotype benefits most - is a topic of current research.

来源:Respiration,查看原文。版权归原作者所有。

参考来源

  1. Bonta PI, Chanez P, Annema JT, et al. Bronchial Thermoplasty in Severe Asthma: Best Practice Recommendations from an Expert Panel. Respiration. 2018. PMID: 29669351. doi:10.1159/000488291

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。